This Month
- Exclusive
- Weight loss
Ozempic maker wants taxpayer subsidy for new Wegovy drug
Danish pharmaceutical giant Novo Nordisk pulled in more than $600 million from Australia last year but reported just $17 million in profit here.
- Nick Bonyhady
Can a healthy diet help autistic children to thrive?
It’s early days but researchers are hopeful that diet could be a key factor in easing some symptoms of the condition.
- David Cox
- Exclusive
- Weight loss
Next blockbuster weight-loss drug to launch in Australia this month
Novo Nordisk’s Wegovy is about to go on sale here, avoiding the prospect of a supply disaster when compounded Ozempic is banned.
- Updated
- Nick Bonyhady
July
- Opinion
- The AFR View
Beware propping up ‘bricks and mortar’ hospitals disrupted by ‘virtual care’
Australia needs a big picture reimagining of how to organise and pay for the kind of healthcare services an ageing society needs, setting aside scare tactics about ‘US-style managed care’.
- The AFR View
- Opinion
- Education
Time running out to fix school funding sticking point
Here we are, 12 years later, with at least one school generation having finished their education, and there’s still no needs-based Gonski funding for disadvantaged students.
- Doug Taylor
CSL wins global avian flu vaccine contracts
Australian pharmaceutical giant CSL is to supply up to 45 million shots of its avian flu vaccine to Europe and the US as health authorities prepare for possible human infection from the dangerous H5 strain.
- Tom Burton
- Opinion
- Fertility
Me, my niece and a generational shift in thinking about babies
The “happy accidents” that led to so many families having three or more children are a lot less likely to happen now.
- Emma Connors
Rich countries are paying women to procreate. It isn’t working
Despite subsidising each new child by $2 million, France has the lowest birth rate in modern history. Other countries have similar problems.
- The Economist
Mental health crisis for young women started in 2012, study finds
More research has found a strong link between the emergence of social media and depression, anxiety and self-harm.
- Julie Hare
- Opinion
- Immigration
Slashing foreign student numbers would be economic self-harm
Before the government puts the squeeze on Australia’s $48 billion university export industry, it should consider how much GDP it is prepared to sacrifice.
- Bran Black
June
Why people with cancer don’t get the full benefit of clinical trials
Australian researchers say regulators should mandate the requirement to share data.
- Jill Margo
- Opinion
- Culture wars
The educated elite is destroying America
Progressive culture has spread from the universities to national life, triggering a backlash that benefits political populists such as Donald Trump.
- David Brooks
- Opinion
- Hospitals
The bottom line is private hospitals are evolving, not collapsing
The government’s “financial health check” review should kick-start a conversation about innovation and the fate of some old, inefficient facilities.
- Matthew Koce
- Opinion
- The AFR View
Australia’s anticompetitive pharmacy regime
The competition watchdog should also be analysing how Australia’s anticompetitive pharmacy policy settings – much like labour monopolies on construction sites and on the wharfs – are substantially lessening competition.
- The AFR View
NSW unis in a sea of red, but worse to come
NSW universities struggled for a second year in a row, but their annus horribilis is still on the horizon.
- Julie Hare
The trouble with psychedelics
The gold-standard methodology for testing a drug’s efficacy, the double-blind trial, does not work for substances that affect the mind.
- Jonathan Lambert
- Exclusive
- International students
2000 jobs lost in foreign education sector the ‘tip of the iceberg’
The Albanese government’s migration cuts have triggered staff cutbacks at colleges and recruitment firms, and at least one university has imposed a hiring freeze.
- Julie Hare
